Trial
NCT02105350
A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University Health Network, Toronto
Collaborators
—
Condition
Biliary Tract Carcinoma
Intervention
MEK 162
Why stopped
Study was never initiated
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-02-19